Regencell Bioscience Holdings (RGC) Property, Plant & Equipment (Net) (2020 - 2025)

Regencell Bioscience Holdings (RGC) Property, Plant & Equipment (Net) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 4.00 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 3.72 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 1.84 Bn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 185.80 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 90.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 1.40 Bn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 220.59 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 157.56 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 333.85 Mn
10 Regencell Bioscience Holdings - - - 176,429.00

Historic Data

Download Data
DateValue
Dec 31, 2025 176,429.00
Dec 31, 2025 176,429.00
Jun 30, 2025 215,434.00
Jun 30, 2025 215,434.00
Jun 30, 2024 141,734.00
Jun 30, 2024 141,734.00
Jun 30, 2023 440,829.00
Jun 30, 2023 440,829.00
Jun 30, 2022 712,594.00
Jun 30, 2022 712,594.00
Jun 30, 2021 81,865.00
Jun 30, 2021 81,865.00
Jun 30, 2020 108,321.00
Jun 30, 2020 108,321.00